Loading organizations...
Loading organizations...
Pharmaceutical company focused on transdermal technology and systems.
TTS Pharma has raised $13.9M across 2 funding rounds.
TTS Pharma has raised $13.9M in total across 2 funding rounds.
TTS Pharma has raised $13.9M in total across 2 funding rounds.
TTS Pharma's investors include The North West Fund for Venture Capital.
TTS Pharma has raised $13.9M across 2 funding rounds. Most recently, it raised $13.1M Series B in May 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 23, 2019 | $13.1M Series B | ||
| Dec 1, 2012 | $880K Other Equity | The North West Fund for Venture Capital |